Traci M. Blonquist

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman et al. · The Lancet Oncology · 2015 · 234 citations

Medicine, Microbiology, Open-label Phase 3 +1

Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

Michael Xiang, Haesook Kim, Vincent T. Ho et al. · Blood · 2016 · 113 citations · Full text

Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001

Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris et al. · Blood Advances · 2018 · 113 citations · Full text

Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana‐Farber Cancer Institute ALL Consortium Protocols (2000–2010)

Kira Bona, Traci M. Blonquist, Donna Neuberg et al. · Pediatric Blood & Cancer · 2016 · 105 citations

Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis

Maryam Movassaghian, Andrew M. Brunner, Traci M. Blonquist et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 94 citations

Hematological Malignancy, Isolated Ms, Medicine +11